featured-image

AbbVie, Inc. ( NYSE: ABBV ) Goldman Sachs 45th Annual Global Healthcare Conference June 12, 2024 10:00 AM ET Company Participants Robert Michael - President & COO Jeffrey Stewart - EVP & Chief Commercial Officer Roopal Thakkar - SVP & Chief Medical Officer, Global Therapeutics Scott Reents - EVP & CFO Conference Call Participants Chris Shibutani - Goldman Sachs Chris Shibutani Welcome everybody. Glad that you can join us.

My name is Chris Shibutani, member at the Goldman Sachs Healthcare Research team. We are thrilled to have such a great representation from AbbVie across the C-suite, including our incoming CEO, Chief Operating Officer currently and President, Rob Michael, who we spoke last year. Robert Michael Yes.



Chris Shibutani We should -- everybody should listen very carefully to what you say, because you mean what you say. So we'll look forward to this conversation as well. Scott Reents, Chief Financial Officer; sorry, Jeff Stewart.

We do have Scott, who is present here. Is he in the ecosystem? He is kind of hiding. So we'll see how much he can escape.

And then Roopal Thakkar from the Research Organization. So thank you very much for joining us. Robert Michael Thanks for having us, Chris.

Question-and-Answer Session Q - Chris Shibutani We always manage to find or maybe it's always the case for AbbVie that there are some sentinel junctures. It's hard to keep you guys out of the spotlight, but we're post 2023, such a momentous year. You guys navigated extremely well thro.

Back to Fashion Page